Ozge Besci, MD (she/her/hers)

MD
UNIVERSITY OF MICHIGAN
Ann Arbor, MI, United States

Ozge Besci, MD, is a pediatric endocrinologist, and is currently working as a Postdoctoral Research Fellow in Metabolism, Endocrinology, and Diabetes at the University of Michigan. Her research focuses on lipodystrophy syndromes, including the investigation of disease mechanisms through multicenter cohort studies and proteome-wide autoantibody profiling. Dr. Besci has contributed to large international collaborative studies examining the clinical and metabolic characteristics of rare endocrine disorders.

Disclosure information not submitted.

Presentation(s):

• SAT-653 - Cardiovascular Burden in Lipodystrophy Syndromes: Findings from the LD-Lync Study

  Saturday, June 13, 2026
  9:30 AM - 4:30 PM CT

• SAT-687 - Recognizing an Important Clinical Association: Mitochondrial Disease and Lipomatosis

  Saturday, June 13, 2026
  9:30 AM - 4:30 PM CT

• ORF07-03 - Cardiovascular Burden in Lipodystrophy Syndromes: Findings from the LD-Lync Study

  Saturday, June 13, 2026
  9:55 AM - 10:00 AM CT

• SUN-671 - Integrative Genomics Reveals Molecular Drivers of Lipodystrophy in the RADIANT Study

  Sunday, June 14, 2026
  9:00 AM - 4:00 PM CT

• SUN-674 - Identifying Lipodystrophy in Atypical Diabetes Using a High-Specificity Clinical Prediction Model: Insights from the RADIANT Study

  Sunday, June 14, 2026
  9:00 AM - 4:00 PM CT

• MON-675 - Lmna T10I and R482Q mice have reduced voluntary running, energy metabolism, and altered adipose gene expression in the absence of lipodystrophy

  Monday, June 15, 2026
  9:00 AM - 2:00 PM CT

• MON-676 - Cancer Burden Across Lipodystrophy Subtypes: Results from the LD-Lync Study

  Monday, June 15, 2026
  9:00 AM - 2:00 PM CT

• MON-682 - Metreleptin improves truncal fat percentages and metabolic parameters over long-term in Madelung Disease caused by bi-allelic pathogenic variants in MFN2

  Monday, June 15, 2026
  9:00 AM - 2:00 PM CT

• MON-694 - Distinct Clinical Features of Acquired and Genetic Lipodystrophy Syndromes: Results from the LD-Lync Study

  Monday, June 15, 2026
  9:00 AM - 2:00 PM CT

• ORF44-04 - Beyond Perilipin-1: Proteome-Wide Antibody Profiling Reveals Novel Shared Target Autoantigens in Acquired Lipodystrophy Syndromes

  Monday, June 15, 2026
  9:45 AM - 10:00 AM CT